全球主动脉瘤市场规模、份额、趋势和成长分析报告（2026-2034年）

预计主动脉瘤市场将从 2025 年的 73.2 亿美元成长到 2034 年的 121.8 亿美元，2026 年至 2034 年的复合年增长率为 5.82%。

由于心血管疾病盛行率不断上升以及人们对早期诊断意识提升，全球主动脉瘤市场正经历稳定成长。主动脉瘤若不及时治疗，可能导致严重的併发症，因此迫切需要有效的治疗方法。 CT电脑断层扫描和超音波等影像技术的进步提高了检出率。此外，微创手术，例如血管内主动脉瘤修復术（EVAR），也越来越普及。

成长要素包括全球人口老化以及高血压和吸烟等风险因素的增加。医疗服务提供者正致力于开展预防性筛检项目，以识别高风险患者。外科手术设备、血管支架技术和医院基础设施的改进，促进了治疗方法的普及。已开发国家和开发中国家医疗费用支出的成长，也进一步推动了市场发展。

预计未来成长将主要得益于创新医疗设备的研发和病患监测系统的改进。对更安全、更耐用的移植物材料的研究有望改善长期治疗效果。新兴市场先进疗法的普及将创造新的机会。总体而言，血管治疗和预防性筛检的持续进步将塑造主动脉瘤市场的长期前景。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

• 市场谱系展望
• 渗透率和成长前景分析
• 价值链分析
• 法律规范
  • 标准与合规性
  • 监管影响分析
• 市场动态
  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场挑战
• 波特五力分析
• PESTLE分析

第四章：全球主动脉瘤市场：依类型划分

• 市场分析、洞察与预测
• 胸主动脉瘤
• 腹部主动脉血管瘤
• 腹部主动脉血管瘤
• 颈主动脉瘤

第五章：全球主动脉瘤市场：依诊断方法划分

• 市场分析、洞察与预测
• 超音波
• 电脑断层扫描
• MRI
• X射线
• 血管造影术

第六章：全球主动脉瘤市场：依治疗类型划分

• 市场分析、洞察与预测
• 手术修復
• 血管内动脉瘤修復术
• 药物
• 监测

第七章 全球主动脉瘤市场：依最终用户划分

• 市场分析、洞察与预测
• 医院
• 门诊手术中心
• 诊断检查室
• 专科诊所

第八章 全球主动脉瘤市场：依地区划分

• 区域分析
• 北美市场分析、洞察与预测
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲市场分析、洞察与预测
  • 英国
  • 法国
  • 德国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太市场分析、洞察与预测
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 东南亚
  • 其他亚太国家
• 拉丁美洲市场分析、洞察与预测
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他拉丁美洲国家
• 中东和非洲市场分析、洞察与预测
  • 沙乌地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中东和非洲国家

第九章 竞争情势

• 最新趋势
• 公司分类
• 供应链和销售管道合作伙伴（根据现有资讯）
• 市场占有率和市场定位分析（基于现有资讯）
• 供应商情况（基于现有资讯）
• 策略规划

第十章：公司简介

• 主要公司的市占率分析
• 公司简介
  • Sutas
  • Cook Medical
  • Abbott
  • Cypress Medical
  • Endologix
  • Boston Scientific
  • Phillips
  • Johnson & Johnson
  • Aptus Endosystems
  • Biotronik
  • Cardinal Health

The Aortic Aneurysm Market size is expected to reach USD 12.18 Billion in 2034 from USD 7.32 Billion (2025) growing at a CAGR of 5.82% during 2026-2034.

The Global Aortic Aneurysm Market is witnessing steady growth due to the rising prevalence of cardiovascular diseases and increasing awareness about early diagnosis. Aortic aneurysms, if untreated, can lead to severe complications, creating a strong need for effective treatment options. Technological advancements in imaging techniques such as CT scans and ultrasound are improving detection rates. Minimally invasive procedures like endovascular aneurysm repair (EVAR) are also gaining popularity.

Key drivers include the aging global population and growing risk factors such as hypertension and smoking. Healthcare providers are focusing on preventive screening programs to identify high-risk patients. Improvements in surgical devices, stent graft technologies, and hospital infrastructure are supporting treatment adoption. Increased healthcare spending in both developed and developing countries is further boosting the market.

Future growth is expected to be supported by innovative device development and better patient monitoring systems. Research into safer and more durable graft materials may improve long-term outcomes. Expanding access to advanced treatment in emerging markets will create new opportunities. Overall, ongoing advancements in vascular care and preventive screening will shape the long-term outlook of the Aortic Aneurysm Market.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Type

• Thoracic Aortic Aneurysm
• Abdominal Aortic Aneurysm
• Thoracoabdominal Aortic Aneurysm
• Cervical Aortic Aneurysm

By Diagnosis Method

• Ultrasound
• CT Scan
• MRI
• X-Ray
• Angiography

By Treatment Type

• Surgical Repair
• Endovascular Aneurysm Repair
• Medication
• Monitoring

By End User

• Hospitals
• Ambulatory Surgical Centers
• Diagnostic Laboratories
• Specialty Clinics

COMPANIES PROFILED

• Sutas, Cook Medical, Abbott, Cypress Medical, Endologix, Boston Scientific, Phillips, Johnson Johnson, Aptus Endosystems, Biotronik, Cardinal Health
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL AORTIC ANEURYSM MARKET: BY TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Type
• 4.2. Thoracic Aortic Aneurysm Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Abdominal Aortic Aneurysm Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Thoracoabdominal Aortic Aneurysm Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Cervical Aortic Aneurysm Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL AORTIC ANEURYSM MARKET: BY DIAGNOSIS METHOD 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Diagnosis Method
• 5.2. Ultrasound Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. CT Scan Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. MRI Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. X-Ray Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Angiography Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL AORTIC ANEURYSM MARKET: BY TREATMENT TYPE 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Treatment Type
• 6.2. Surgical Repair Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Endovascular Aneurysm Repair Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Medication Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Monitoring Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL AORTIC ANEURYSM MARKET: BY END USER 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast End User
• 7.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Ambulatory Surgical Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Diagnostic Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.5. Specialty Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL AORTIC ANEURYSM MARKET: BY REGION 2022-2034(USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Type
  • 8.2.2 By Diagnosis Method
  • 8.2.3 By Treatment Type
  • 8.2.4 By End User
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Type
  • 8.3.2 By Diagnosis Method
  • 8.3.3 By Treatment Type
  • 8.3.4 By End User
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Type
  • 8.4.2 By Diagnosis Method
  • 8.4.3 By Treatment Type
  • 8.4.4 By End User
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Type
  • 8.5.2 By Diagnosis Method
  • 8.5.3 By Treatment Type
  • 8.5.4 By End User
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 South East Asia
  • 8.5.10 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Type
  • 8.6.2 By Diagnosis Method
  • 8.6.3 By Treatment Type
  • 8.6.4 By End User
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL AORTIC ANEURYSM INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 Sutas
  • 10.2.2 Cook Medical
  • 10.2.3 Abbott
  • 10.2.4 Cypress Medical
  • 10.2.5 Endologix
  • 10.2.6 Boston Scientific
  • 10.2.7 Phillips
  • 10.2.8 Johnson & Johnson
  • 10.2.9 Aptus Endosystems
  • 10.2.10 Biotronik
  • 10.2.11 Cardinal Health